The 2024 GLOBOCAN report highlights a projected increase in the global burden of cancer from 20 million new diagnoses in 2022, to 35 million in 2050.1 Radiotherapy and theranostics: a Lancet Oncology ...

Radiotherapy and theranostics are crucial in cancer management, with more than 50% of patients with cancer needing ...

In 2015, the Lancet Oncology Commission on expanding global access to radiotherapy laid out the first evidence-based case for global investment in radiotherapy by showing substantial health and ...

The 2015 Lancet Oncology Commission on expanding global access to radiotherapy1 was a pivotal moment in global oncology. It highlighted disparities in radiotherapy access and revealed radiotherapy ...

A 57-year-old woman with a 12-h history of fever and severe pain in her back, pelvis, and thighs attended our hospital. 24 h ...

Rabies, a preventable yet fatal disease, continues to claim 59 000 lives annually, with Africa shouldering over 60% of this ...

Community built environment features recorded in photographs, including bike lanes, pedestrian safety measures, ...

On Aug 14, 2024, WHO re-declared mpox (formerly known as monkeypox) as a public health emergency of international concern ...

Nicknamed “the beast”, Georgetown University star football player David Fajgenbaum had always envisioned a career in athletics. But when his mother was diagnosed with glioblastoma, Fajgenbaum changed ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

Antimicrobial resistance (AMR) and the inability to treat infections affects everyone, especially individuals in low-income and middle-income countries (LMICs) and the most vulnerable groups, such as ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...